| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20029477 | HPV | ENSG00000088179.9 | protein_coding | PTPN4 | No | No | 5775 | P29074 |
| TVIS44030955 | HTLV-1 | ENSG00000088179.9 | protein_coding | PTPN4 | No | No | 5775 | P29074 |
| TVIS44018762 | HTLV-1 | ENSG00000088179.9 | protein_coding | PTPN4 | No | No | 5775 | P29074 |
| TVIS44015094 | HTLV-1 | ENSG00000088179.9 | protein_coding | PTPN4 | No | No | 5775 | P29074 |
| TVIS44012136 | HTLV-1 | ENSG00000088179.9 | protein_coding | PTPN4 | No | No | 5775 | P29074 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PTPN4 |
|---|---|
| DrugBank ID | DB00630 |
| Drug Name | Alendronic acid |
| Target ID | BE0000980 |
| UniProt ID | P29074 |
| Regulation Type | inhibitor |
| PubMed IDs | 9310349 |
| Citations | Opas EE, Rutledge SJ, Golub E, Stern A, Zimolo Z, Rodan GA, Schmidt A: Alendronate inhibition of protein-tyrosine-phosphatase-meg1. Biochem Pharmacol. 1997 Sep 15;54(6):721-7. |
| Groups | Approved |
| Direct Classification | Bisphosphonates |
| SMILES | NCCCC(O)(P(O)(O)=O)P(O)(O)=O |
| Pathways | Alendronate Action Pathway |
| PharmGKB | PA448082 |
| ChEMBL | CHEMBL870 |
